Skip to content

Prestige Consumer Healthcare

US · PBH #2733 by market cap Listed 1970
49.63 +0.03 +0.06%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Cuts Target Price to $70
    Market Newswire · 2026/11/6
  • Rating change
    Analysts Offer Insights on NA Companies: Springer Nature AG & Co. KGaA (OtherSPGDF) and Prestige Consumer Healthcare (PBH)
    TipRanks · 2026/8/6
  • Company notice
    Prestige Consumer Healthcare | 10-Q: Q2 2027 Earnings Report
    SEC · 2026/11/5
  • Rating change
    Research Alert: Pbh Q1: Revenue Up 25% To Cad2.1b On Stampede Deal; Maintains 2026 Guidance
    MT Newswires · 2026/5/7
  • Rating change
    CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $86
    Market Newswire · 2026/3/23
  • Rating change
    William Blair Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating
    Market Newswire · 2026/8/6
  • Company notice
    Prestige Consumer Healthcare | 8-K: Prestige Consumer Healthcare Inc. Reports Fiscal 2027 Second Quarter Results
    SEC · 2026/11/5
  • Company notice
    Prestige Consumer Healthcare | 8-K: Current report
    SEC · 2026/8/15
  • Rating change
    Oppenheimer Downgrades Prestige Consumer Healthcare(PBH.US) to Hold Rating
    Market Newswire · 2026/5/14
  • Rating change
    CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $72
    Market Newswire · 2026/8/8
  • Company notice
    8-K: Prestige Consumer Healthcare | 8-K: Current report
    SEC · 2026/8/6
  • Rating change
    CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Cuts Target Price to $72
    Market Newswire · 2026/5/15
  • Rating change
    Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Announces Target Price $65
    Market Newswire · 2026/5/7
  • Rating change
    Prestige Consumer Healthcare: Buy Rating Reaffirmed Despite Soft Outlook, With Acquisitions and Undervalued Earnings Power Seen as Upside Drivers
    TipRanks · 2026/5/14
  • Prestige Consumer Healthcare Down Over 17%, on Pace for Largest Percent Decrease Since May 2010 -- Data Talk
    Dow Jones · 2026/11/6
  • Company notice
    10-Q: Prestige Consumer Healthcare | 10-Q: Q1 2027 Earnings Report
    SEC · 2026/8/6
  • Prestige Consumer Healthcare Shares Tumble on Cut to Outlook, Lower 2Q Profit
    WSJ · 2026/11/6
  • Rating change
    Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $65 From $77, Maintains Outperform Rating
    MT Newswires · 2026/5/7
  • Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference
    GlobeNewswire · 2026/8/11
  • Premium Brands Holdings Gets TSX Approval for Normal Course Issuer Bid PBH.T
    Dow Jones · 2026/10/14
  • Company notice
    Prestige Consumer Healthcare | 4: Statement of changes in beneficial ownership of securities
    SEC · 2026/8/6
  • Company notice
    Prestige Consumer Healthcare | 4: Statement of changes in beneficial ownership of securities
    SEC · 2026/8/6
  • Premium Brands Holdings: Board Approves NCIB for Repurchase of Up to 1M Common Shares PBH.T
    Dow Jones · 2026/10/1
  • Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results
    GlobeNewswire · 2026/10/14
  • Prestige Consumer Healthcare Lifts Outlook After Strong Q1
    TipRanks · 2026/8/23

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Prestige Consumer Healthcare discussion 0 comments

Add a comment